Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 452

1.

A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.

Catassi C, Fabiani E, Iacono G, D'Agate C, Francavilla R, Biagi F, Volta U, Accomando S, Picarelli A, De Vitis I, Pianelli G, Gesuita R, Carle F, Mandolesi A, Bearzi I, Fasano A.

Am J Clin Nutr. 2007 Jan;85(1):160-6.

2.

Gluten tolerance in adult patients with celiac disease 20 years after diagnosis?

Hopman EG, von Blomberg ME, Batstra MR, Morreau H, Dekker FW, Koning F, Lamers CB, Mearin ML.

Eur J Gastroenterol Hepatol. 2008 May;20(5):423-9. doi: 10.1097/MEG.0b013e3282f4de6e.

PMID:
18403944
3.

Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.

Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, Marcantonio A, Adelman DC, Mäki M.

Gastroenterology. 2014 Jun;146(7):1649-58. doi: 10.1053/j.gastro.2014.02.031. Epub 2014 Feb 25.

PMID:
24583059
4.

Clinical trial: gluten microchallenge with wheat-based starch hydrolysates in coeliac disease patients - a randomized, double-blind, placebo-controlled study to evaluate safety.

Kaukinen K, Salmi T, Collin P, Huhtala H, Kärjä-Lahdensuu T, Mäki M.

Aliment Pharmacol Ther. 2008 Nov 15;28(10):1240-8. doi: 10.1111/j.1365-2036.2008.03832.x. Epub 2008 Aug 17.

5.

Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.

Kurppa K, Collin P, Viljamaa M, Haimila K, Saavalainen P, Partanen J, Laurila K, Huhtala H, Paasikivi K, Mäki M, Kaukinen K.

Gastroenterology. 2009 Mar;136(3):816-23. doi: 10.1053/j.gastro.2008.11.040. Epub 2008 Nov 24.

PMID:
19111551
6.
7.

Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten.

Selby WS, Painter D, Collins A, Faulkner-Hogg KB, Loblay RH.

Scand J Gastroenterol. 1999 Sep;34(9):909-14.

PMID:
10522611
8.

Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge.

Adriaanse MP, Leffler DA, Kelly CP, Schuppan D, Najarian RM, Goldsmith JD, Buurman WA, Vreugdenhil AC.

Am J Gastroenterol. 2016 Jul;111(7):1014-22. doi: 10.1038/ajg.2016.162. Epub 2016 May 17.

PMID:
27185075
9.

Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.

Stenman SM, Lindfors K, Korponay-Szabo IR, Lohi O, Saavalainen P, Partanen J, Haimila K, Wieser H, Mäki M, Kaukinen K.

BMC Immunol. 2008 Feb 29;9:6. doi: 10.1186/1471-2172-9-6.

10.

Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease.

Cellier C, Cervoni JP, Patey N, Leborgne M, Marteau P, Landi B, Cerf-Bensussan N, Barbier JP, Brousse N.

Am J Gastroenterol. 1998 Sep;93(9):1527-30.

PMID:
9732937
11.

Gluten challenge in borderline gluten-sensitive enteropathy.

Wahab PJ, Crusius JB, Meijer JW, Mulder CJ.

Am J Gastroenterol. 2001 May;96(5):1464-9.

PMID:
11374684
12.

Antiendomysial antibody detection in biopsy culture allows avoidance of gluten challenge in celiac children.

Bonamico M, Sabbatella L, Di Tola M, Vetrano S, Ferri M, Nenna R, Mariani P, Picarelli A.

J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):165-9; discussion 122-4.

PMID:
15699690
13.

Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease.

Kurppa K, Paavola A, Collin P, Sievänen H, Laurila K, Huhtala H, Saavalainen P, Mäki M, Kaukinen K.

Gastroenterology. 2014 Sep;147(3):610-617.e1. doi: 10.1053/j.gastro.2014.05.003. Epub 2014 May 13.

PMID:
24837306
14.

Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.

Kaukinen K, Peräaho M, Collin P, Partanen J, Woolley N, Kaartinen T, Nuutinen T, Halttunen T, Mäki M, Korponay-Szabo I.

Scand J Gastroenterol. 2005 May;40(5):564-72.

PMID:
16036509
15.

Even small amounts of gluten cause relapse in children with celiac disease.

Laurin P, Wolving M, Fälth-Magnusson K.

J Pediatr Gastroenterol Nutr. 2002 Jan;34(1):26-30.

PMID:
11753160
16.

Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.

Verbeek WH, von Blomberg BM, Coupe VM, Daum S, Mulder CJ, Schreurs MW.

Cytometry B Clin Cytom. 2009 Nov;76(6):367-74. doi: 10.1002/cyto.b.20481.

17.

Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study.

Addolorato G, Capristo E, Ghittoni G, Valeri C, Mascianà R, Ancona C, Gasbarrini G.

Scand J Gastroenterol. 2001 May;36(5):502-6.

PMID:
11346203
18.

Urinary nitric oxide during one year of gluten-free diet with or without oats in children with coeliac disease.

Hollén E, Forslund T, Högberg L, Laurin P, Stenhammar L, Fälth-Magnusson K, Magnusson KE, Sundqvist T.

Scand J Gastroenterol. 2006 Nov;41(11):1272-8.

PMID:
17060120
19.

Compliance with gluten-free diet in children with coeliac disease.

Jadresin O, Misak Z, Sanja K, Sonicki Z, Zizić V.

J Pediatr Gastroenterol Nutr. 2008 Sep;47(3):344-8. doi: 10.1097/MPG.0b013e31816f856b.

PMID:
18728532
20.

The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease?

Collin P, Thorell L, Kaukinen K, Mäki M.

Aliment Pharmacol Ther. 2004 Jun 15;19(12):1277-83. Review.

Supplemental Content

Support Center